company background image
500488 logo

Abbott India BSE:500488 Stock Report

Last Price

₹28.64k

Market Cap

₹608.5b

7D

-0.07%

1Y

26.8%

Updated

20 Dec, 2024

Data

Company Financials +

Abbott India Limited

BSE:500488 Stock Report

Market Cap: ₹608.5b

500488 Stock Overview

Operates as a pharmaceutical company in India. More details

500488 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Rewards

Earnings are forecast to grow 10.86% per year

Earnings have grown 17.2% per year over the past 5 years

Risk Analysis

Dividend of 1.43% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Abbott India Limited Competitors

Alkem Laboratories

NSEI:ALKEM

₹648.9b

Aurobindo Pharma

NSEI:AUROPHARMA

₹721.2b

Lupin

BSE:500257

₹979.7b

Zydus Lifesciences

NSEI:ZYDUSLIFE

₹979.6b

Price History & Performance

Summary of share price highs, lows and changes for Abbott India
Historical stock prices
Current Share Price₹28,637.70
52 Week High₹30,499.90
52 Week Low₹22,250.00
Beta0.019
1 Month Change5.31%
3 Month Change1.49%
1 Year Change26.84%
3 Year Change55.39%
5 Year Change117.18%
Change since IPO4,924.16%

Recent News & Updates

Recent updates

Shareholder Returns

500488IN PharmaceuticalsIN Market
7D-0.07%0.8%-4.2%
1Y26.8%39.7%19.1%

Return vs Industry: 500488 underperformed the Indian Pharmaceuticals industry which returned 43.7% over the past year.

Return vs Market: 500488 exceeded the Indian Market which returned 22.5% over the past year.

Price Volatility

Is 500488's price volatile compared to industry and market?
500488 volatility
500488 Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 500488 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 500488's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19103,814Swati Dalalwww.abbott.co.in

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.

Abbott India Limited Fundamentals Summary

How do Abbott India's earnings and revenue compare to its market cap?
500488 fundamental statistics
Market cap₹608.53b
Earnings (TTM)₹12.85b
Revenue (TTM)₹60.66b

47.4x

P/E Ratio

10.0x

P/S Ratio

Is 500488 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500488 income statement (TTM)
Revenue₹60.66b
Cost of Revenue₹33.43b
Gross Profit₹27.23b
Other Expenses₹14.39b
Earnings₹12.85b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)604.57
Gross Margin44.89%
Net Profit Margin21.18%
Debt/Equity Ratio0%

How did 500488 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

73%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 08:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abbott India Limited is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Abdulkader PuranwalaAnand Rathi Shares and Stock Brokers Limited
Shareen BatatawalaAngel Broking Private Limited
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.